Key result
Current serum iron markers fail to reflect cellular iron levels in HF, risking iron overload.
Why the study?
Although trials show symptomatic benefit of intravenous iron in heart failure with low serum iron, systemic and cellular mechanisms of iron homeostasis remain poorly understood and current definitions may include patients who do not need intravenous iron.
This review highlights the critical distinction between systemic and cellular iron homeostasis, cautioning against the liberal use of intravenous iron in heart failure based solely on conventional serum markers.
Answers are grounded in this paper and cite their sources.
Caution against IV iron in HF based on serum markers alone; leaves open development of cellular iron assays for trials.
To date, 3 clinical trials have shown symptomatic benefit from the use of intravenous (IV) iron in patients with heart failure (HF) with low serum iron. This has led to recommendations in support of the use of IV iron in this population. However, the systemic and cellular mechanisms of iron homeostasis in cardiomyocyte health and disease are distinct, complex, and poorly understood. Iron metabolism in HF appears dysregulated, but it is still unclear whether the changes are maladaptive and pathologic or compensatory and protective for the cardiomyocytes. The serum markers of iron deficiency in HF do not accurately reflect cellular and mitochondrial iron levels, and the current definition based on the ferritin and transferrin saturation values is broad and inclusive of patients who do not need IV iron. This is particularly relevant in view of the potential risks that are associated with the use of IV iron. Reliable markers of cellular iron status may differentiate subgroups of HF patients who would benefit from cellular and mitochondrial iron chelation rather than IV iron.
No takes yet. Share an insight, caveat, or question.
Ghafourian et al. (2020) conducted a review in Heart failure. Intravenous iron was evaluated. Current serum markers for iron deficiency in heart failure do not accurately reflect cellular iron levels, potentially leading to unnecessary intravenous iron administration and cellular iron overload.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: